← Back to Analyst Consensus 
JAZZ Buy
Jazz Pharmaceuticals plc
Current Price —
Implied Upside —
Analysts 28
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Next Earnings
Nov 2, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Oct 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Sep 30, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Sep 11, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Sep 10, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 26, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Aug 26, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 26, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 26, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Aug 11, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 4, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 4, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Aug 4, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 4, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jul 20, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 17, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Jul 14, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 14, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 9, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Jul 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 10, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 27, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 22, 2026 | Bernstein | initiate | — → Market Perform | — | 52% |
| May 22, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 19, 2026 | UBS | upgrade | Neutral → Buy | — | 54% |
| May 6, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 6, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 24, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 22, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Apr 20, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 19, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Feb 27, 2026 | Barclays | initiate | — → Overweight | $224 | 53% |
| Feb 25, 2026 | RBC Capital | maintain | Outperform → Outperform | $195 | 55% |
| Feb 25, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $226 | 54% |
| Feb 25, 2026 | Wells Fargo | maintain | Overweight → Overweight | $250 | 54% |
| Feb 25, 2026 | B of A Securities | maintain | Buy → Buy | $275 | 53% |
| Jan 12, 2026 | Truist Securities | maintain | Buy → Buy | $230 | 54% |
| Jan 12, 2026 | Needham | maintain | Buy → Buy | $235 | 50% |
| Dec 10, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $219 | 54% |
| Nov 24, 2025 | UBS | downgrade | Buy → Neutral | $188 | 54% |
| Nov 18, 2025 | Wells Fargo | maintain | Overweight → Overweight | $235 | 54% |
| Nov 18, 2025 | Baird | maintain | Outperform → Outperform | $209 | 55% |
Price Target Trend
Jul 2, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days